Related Experiment Video
Updated: Nov 30, 2025
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Intentional Stent Stenosis to Prevent Hyperperfusion Syndrome after Carotid Artery Stenting for Extremely High-Grade
T Mori1, K Yoshioka2, Y Tanno2
1From the Department of Stroke Treatment, Shonan Kamakura General Hospital, Kamakura, Japan. morit-koc@umin.net.
Insights
Gentle carotid artery stent placement, involving intentional residual stenosis, effectively prevents hyperperfusion syndrome in high-risk patients. Stents demonstrated spontaneous dilation over four months, ensuring long-term safety.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Radiology
Background:
- Intracranial hemorrhage is a severe complication of carotid artery stent placement for high-grade stenosis.
- Hyperperfusion syndrome, caused by hemodynamic insufficiency, poses a significant risk.
- Preventing this complication is crucial for patient safety.
Purpose of the Study:
- To investigate the efficacy of a "gentle" carotid artery stent placement technique in preventing hyperperfusion syndrome.
- To evaluate long-term outcomes associated with this novel approach.
Main Methods:
- Patients with extremely high-grade carotid stenosis (defined by "slow flow" and reduced MCA signal intensity) were included.
- A "gentle" stent placement involved closed-cell stents with slight predilation, no postdilation, and intentional residual stenosis.
- Hyperperfusion syndrome was defined by ipsilateral headache, seizure, or hemiparesis.
Main Results:
- Out of 191 patients, 28 met the inclusion criteria.
- Median minimal stent diameter was 2.9 mm, expanding to 3.9 mm at 4 months.
- No cases of cerebral hyperperfusion syndrome or intracranial hemorrhage were observed.
Conclusions:
- The "gentle" carotid artery stent placement strategy, with intentional residual stenosis, effectively prevents hyperperfusion syndrome.
- Spontaneous stent dilation occurred within 4 months, indicating favorable long-term results.
Background And Purpose:
Intracranial hemorrhage due to hyperperfusion syndrome is a severe carotid artery stent placement complication of extremely high-grade stenosis, causing hemodynamic insufficiency. To prevent hyperperfusion syndrome, we attempted intentional residual stent stenosis and implemented "gentle" carotid artery stent placement, defined as carotid artery stent placement using a closed-cell stent coupled with slight balloon predilation, without balloon postdilation. Gradual stent expansion was expected. We investigated the incidence of hyperperfusion syndrome and long-term outcomes after gentle carotid artery stent placement.
Materials And Methods:
We included patients who underwent carotid artery stent placement for extremely high-grade stenosis from January 2015 to March 2019. We defined extremely high-grade stenosis as carotid stenosis with conventional angiographic "slow flow" and a reduced MCA signal intensity on MRA. A reduced MCA signal intensity was defined as MCA with a relative signal intensity of <0.9 in the ipsilateral compared with the contralateral MCA. We evaluated the stent diameter, CBF on SPECT, hyperperfusion syndrome, and intracranial hemorrhage. We defined hyperperfusion syndrome as a triad of ipsilateral headache, seizure, and hemiparesis.
Results:
Twenty-eight of the 191 patients met our inclusion criteria. After carotid artery stent placement, their median minimal stent diameter was 2.9 mm, which expanded to 3.9 mm at 4 months. Neither cerebral hyperperfusion syndrome nor intracranial hemorrhage occurred.
Conclusions:
The gentle carotid artery stent placement strategy for intentional residual stent stenosis may prevent hyperperfusion syndrome in high-risk patients. Stents spontaneously dilated in 4 months.
More Related Videos
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care